about
Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: meta-analysis of three genome-wide association studiesIdentification of genomic predictors of atrioventricular conduction: using electronic medical records as a tool for genome scienceCardiac applications for human pluripotent stem cellsQT interval and antidepressant use: a cross sectional study of electronic health recordsUpdate on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug developmentVentricular repolarization measures for arrhythmic risk stratificationCirrhotic cardiomyopathyNomenclature, categorization and usage of formulae to adjust QT interval for heart rateSex differences in the mechanisms underlying long QT syndromeThe role of concentration-effect relationships in the assessment of QTc interval prolongationCurrent issues on safety of prokinetics in critically ill patients with feed intolerancePharmacogenomics and cardiovascular diseaseTowards a better understanding of QT interval variabilityPharmacological and nonpharmacological management of delirium in critically ill patients.New therapeutic targets in cardiology: arrhythmias and Ca2+/calmodulin-dependent kinase II (CaMKII)Chronopharmacology: new insights and therapeutic implicationsA study of early afterdepolarizations in a model for human ventricular tissue.Domperidone-Associated QT Interval Prolongation in Non-oncologic Pediatric Patients: A Review of the Literature2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theElectrocardiographic Biomarkers for Detection of Drug-Induced Late Sodium Current BlockMarkov models of use-dependence and reverse use-dependence during the mouse cardiac action potentialHigh-throughput 1,536-well fluorescence polarization assays for α(1)-acid glycoprotein and human serum albumin bindingPharmacometabolomic approach to predict QT prolongation in guinea pigsGenome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizesThe FLT3 inhibitor quizartinib inhibits ABCG2 at pharmacologically relevant concentrations, with implications for both chemosensitization and adverse drug interactionsImpact of hypokalemia on electromechanical window, excitation wavelength and repolarization gradients in guinea-pig and rabbit heartsPronounced effects of HERG-blockers E-4031 and erythromycin on APD, spatial APD dispersion and triangulation in transgenic long-QT type 1 rabbitsGlobal analysis reveals families of chemical motifs enriched for HERG inhibitorsElectrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness Analysisα1-Syntrophin Variant Identified in Drug-Induced Long QT Syndrome Increases Late Sodium CurrentTime-to-Onset Analysis of Drug-Induced Long QT Syndrome Based on a Spontaneous Reporting System for Adverse Drug EventsPhIN: A Protein Pharmacology Interaction Network DatabaseAdverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approachFine mapping of QT interval regions in global populations refines previously identified QT interval loci and identifies signals unique to African and Hispanic descent populations.Cardiac models in drug discovery and development: a review.Drug- and non-drug-associated QT interval prolongation.New atypical antipsychotics for schizophrenia: iloperidoneScreening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays.In Silico target fishing: addressing a "Big Data" problem by ligand-based similarity rankings with data fusion.Generalized estimating equations for genome-wide association studies using longitudinal phenotype data.
P2860
Q21143760-1B84D577-871A-4E12-AE56-BEBA184606ABQ24305201-74424CC5-3B23-41D4-8593-0E45286FFB52Q24615347-01D27C19-0FE4-439B-ADFB-1EEC53F36D50Q24629713-C046FBC4-88D0-450F-B6F4-CF79C9512474Q24646866-3490917C-7A07-4ECC-BD34-66816A71A112Q26769982-EA26721E-1EFE-47DA-9E6C-B771F555964FQ26778048-AB7CEB18-998B-4C1A-9324-2412C29D2525Q26852494-FCD1D24C-8448-4AB6-BA62-D80801973CF9Q26862667-3B45941A-A75E-4952-B2C7-9E9B679809ADQ26866417-0AFE9FC6-3FF9-4955-8464-8BFCDF4C4E6EQ26992006-DCB5634C-81E3-4DE2-98D2-94FB646CE778Q26997380-C41D953C-ADD5-4419-B667-BD0FD30E2A50Q27001737-8600249D-E65E-4A88-8FE1-EC71B6029F72Q27005223-D985D933-F88B-4A87-8347-996FE2FE255DQ27016402-39EF39FC-1000-457D-B54A-6B00303E7F9BQ27022411-89D67882-5013-4CE8-ABD7-0A61119C69E9Q27335021-CB8BA811-EDDC-469B-A92E-8542D538A84CQ28073786-D19CEEEB-9C18-4A83-A9A7-6BC529059E15Q28087002-7732F777-84C9-4419-A676-007A89B635D7Q28468470-46A9D3FD-03A9-4478-AFE2-922EE5345F5BQ28482100-7FD982DC-2FA2-4694-B4AF-5168527763F4Q28483928-FDB1ABD3-E4B9-4D16-9207-DD8C1D09372EQ28485993-52525390-8575-45F7-9953-FB2135B03976Q28534878-11D0ADBF-D2A6-4CAE-A050-8EC327BCA605Q28535342-08D9D8E1-D7CA-4AFC-A7AA-018586B842F0Q28542455-32FDCCB7-9841-4AB5-B20D-0DA22E2E7C55Q28543123-33485273-E58E-4803-8946-152BE8BBC365Q28543571-AFA1886B-7C8E-4BFD-AFC1-587E5C6083AEQ28548272-F9A13248-E70D-41E2-BFF9-C1EDF03AB881Q28551060-203BA80A-FF59-4925-B365-53D0A3C640B1Q28554594-DAE9BBE2-93ED-40A3-8CBC-590BAE17F790Q28649771-EB6624B3-BD18-4BA6-BCA8-A5B4E376136EQ28742444-CBBEED89-8476-4E99-B8E1-05F5AE3D09C0Q30275202-127E0468-3A5D-4EBF-BF28-4A2A34A9AB28Q30426852-83C83543-6E09-47F2-AF29-3A884699C98FQ30474909-1E243B66-A71F-4583-88D6-87F5EF7423BCQ30482195-257E8645-CCCA-49A5-A32B-87CF0CB5372FQ30558954-BFD52FAF-4661-489D-A477-44D589B6F984Q30833986-541C24AF-15EE-4476-B4CC-BF5F5C166F9FQ30858387-96F323B4-B254-4CB9-BEEE-C60E29CC3290
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Drug-induced prolongation of the QT interval.
@ast
Drug-induced prolongation of the QT interval.
@en
type
label
Drug-induced prolongation of the QT interval.
@ast
Drug-induced prolongation of the QT interval.
@en
prefLabel
Drug-induced prolongation of the QT interval.
@ast
Drug-induced prolongation of the QT interval.
@en
P356
P1476
Drug-induced prolongation of the QT interval.
@en
P2093
Dan M Roden
P304
P356
10.1056/NEJMRA032426
P407
P577
2004-03-01T00:00:00Z